Evidence review

VIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomic Layers

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `vip-chemo`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/vip-chemo

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-chemo/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/vip-chemo/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/vip-chemo/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/vip-chemo/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why VIP might help you

  1. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.

Why Gabapentin / pregabalin matters for you

  1. Drug: Gabapentin / pregabalin
  2. What it does: Masks neuropathic pain signal; does not repair nerve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • VIP → immune / autonomic

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 5
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.46 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Cytoprotective effect of neuropeptides on cancer stem cells (source s1)

2017 preclinical study on VIP protecting cancer stem cells from chemo drugs.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Vasoactive intestinal peptide enhances growth and angiogenesis in prostate cancer (source s2)

2007 mouse xenograft study.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Pregabalin in Chemotherapy Induced Neuropathic Pain (source s3)

2016 human case series.

Evidence type: Published research.

New Practical Approaches to Chemotherapy-Induced Neuropathic Pain (source s4)

2016 review on CIPN treatments.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) (source s5)

Trial not in chemo patients.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

chemo · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
Evidence · 5 sources · swipe →chain 4c48f50db0ca · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
Reviews find insufficient RCT evidence that gabapentinoids outperform placebo for CIPN pain
sources: s4
preclinical
VIP protects breast cancer stem cells from drug-induced apoptosis in cell models
sources: s1
preclinical
VIP increases tumor growth and angiogenesis in mouse prostate cancer xenograft model
sources: s2
anecdotal
Pregabalin reduced hyperalgesia and allodynia in a small case series of CIPN patients
sources: s3
humanlow confidence
No human trials test VIP peptide for post-chemotherapy recovery or CIPN
sources: s5
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 22:35
VIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomic Layers · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Vip for Chemo
Slug: vip-chemo
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"vip","name":"VIP"}],"drugs_in_scope":["gabapentin-lyrica"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_la
it output
{
  "slug": "vip-chemo",
  "title": "VIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomic Layers",
  "body": "## What's breaking down\n\nChemotherapy often damages nerves, triggers widespread inflammation, and disrupts autonomic signaling. These layers can persist because repair processes lag behind ongoing breakdown. VIP (vasoactive intestinal peptide) is discussed in research for its potential effects on immune modulation and autonomic regulation rather than direct nerve repair or symptom masking.\n\nChemo-induced peripheral neuropathy (CIPN) involves nerve fiber damage and altered calcium signaling in dorsal root ganglia. Inflammatory cytokines rise during treatment. Autonomic imbalance can appear as changes in vascular tone or gut motility. No single peptide addresses all layers at once.\n\n## Why VIP might help you\n\nIf immune or autonomic dysregulation forms part of your post-chemo experience, VIP enters discussions because studies examine its role in tissue-level signaling rather than pain signal suppression.\n\n1. VIP receptors appear on immune cells and autonomic nerve endings.\n2. Preclinical work explores whether VIP influences cytokine balance or vascular responses.\n3. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\n## Why Gabapentin / pregabalin matter
45a8aa9602928e72
Ask this article · 7 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Reviews find insufficient RCT evidence that gabapentinoids outperform placebo for CIPN pain"?
ask vip-chemo claim c4 · paste includes §SELF
What does the ledger say about this (preclinical tier): "VIP protects breast cancer stem cells from drug-induced apoptosis in cell models"?
ask vip-chemo claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "VIP increases tumor growth and angiogenesis in mouse prostate cancer xenograft model"?
ask vip-chemo claim c2 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Pregabalin reduced hyperalgesia and allodynia in a small case series of CIPN patients"?
ask vip-chemo claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials test VIP peptide for post-chemotherapy recovery or CIPN"?
ask vip-chemo claim c5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about VIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomic Layers — and what would you need me to tell you first?
ask vip-chemo condition gaps · paste includes §SELF
What good and bad outcomes are documented for VIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomic Layers (studies vs anecdotes)?
ask vip-chemo good bad experiences · paste includes §SELF
vip-chemo · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 30657 tokens · $0 · 1 model
chain head e810f29b3e68e171
write grok/grok-4.3 · 2026-06-29 22:35 · 30657 tok · e810f29b3e68
verify chain →
Live ledger · 12 payloads · 2 turns
recent activity · inspect
webhook_in blooio · 2026-06-29 22:35
webhook_in blooio · 2026-06-29 22:35
PROTOCOL_RUN dispatch · 2026-06-29 22:35 · t_r4opisul
PROTOCOL_RUN dispatch · 2026-06-29 22:35 · t_r4opisul
webhook_in blooio · 2026-06-29 22:35
webhook_in blooio · 2026-06-29 22:35
view full ledger & cards →
REST + ledger
read GET /api/articles/vip-chemo · GET /api/articles/vip-chemo?format=post (the editable body)
create/replace POST /api/articles/vip-chemo · PUT /api/articles/vip-chemo (replace, keeps revision) · PATCH /api/articles/vip-chemo (merge)
delete DELETE /api/articles/vip-chemo
writes need header x-terminal-key
LLM bundle GET /api/articles/vip-chemo/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim vip-chemo|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →